Infant Formula Market Research & Feasibility Studies

Why Infant Formula Market Research Is Different

Infant formula market research has to combine three things that most generalist market research lacks: deep regulatory understanding (because the regulatory framework substantially shapes what is commercially possible), technical credibility (because the product claims that drive premium positioning are technical), and channel-level understanding (because infant formula channel structure varies hugely between markets and shapes commercial strategy directly).

Generic FMCG market research approaches routinely miss what matters. Watson Dairy Consulting combines infant formula technical depth with structured market research methodology, producing studies that support actual commercial decision-making rather than just summarising publicly available numbers.

What Our Studies Cover

The Key Strategic Questions

Most infant formula market studies are commissioned to support specific decisions. The questions we are most often asked to address:

• Is this market worth entering for our position? Sizing and segment analysis specific to the client's product, brand and price position
• What is the realistic ramp? Channel access realities, regulatory timelines, brand-building lead times in the specific market
• Which segment should we target? Identifying segments with the right combination of size, growth, defensibility against incumbents and fit with our brand
• Who would be the right partner? Independent identification and assessment of potential local partners - regulatory, distribution, brand. See JV & alliances
• What is the right capex strategy? Local production, contract manufacturing, import from existing facility - economic and regulatory implications of each
• What is the right brand architecture? Single brand across markets, market-specific brands, or umbrella with sub-brands

Why Independent Research Matters Specifically for Infant Formula

Infant formula category is unusually exposed to optimistic narratives. Industry trade publications, press releases and broker reports all have systematic biases toward optimism on category growth, premium upside and market entry feasibility. Investors, boards and management teams routinely face decision points where the available analysis is either too generic to be useful or too optimistic to be trusted.

Independent technical and commercial analysis - with no fee dependence on whether the client proceeds with entry - gives the decision-makers something they often do not otherwise have: honest assessment of where the opportunities are real, where they are smaller than they appear, and where the structural barriers are actually binding.

Frequently Asked Questions

What is the size of the global infant formula market?

The global infant formula market is substantial - estimates run into the tens of billions of US dollars annually, with significant variation by region. China remains the largest single market in absolute terms despite declining birth rates; the GCC, Southeast Asia and parts of Africa are growth markets; mature Western markets are flat to declining in volume but evolving in segment mix toward premium and specialised products. We provide specific current numbers as part of any commissioned study.

Which segments are growing?

Premium and super-premium segments (organic, A2, goat, sheep, plant-based alternatives, specialised allergen-free) are growing share in most mature markets. Specialised medical formulas continue to grow with healthcare ageing. Standard commodity infant formula is flat to declining in most developed markets and grew in some emerging markets. Specific segment growth is region-specific.

What are the regulatory hurdles to market entry?

Infant formula has the most demanding regulatory framework in the dairy category. Composition rules vary by jurisdiction (Codex Alimentarius, EU 2016/127, FDA, China SAMR, GCC, country-specific). Registration takes 12 to 36 months in many markets. Manufacturing facilities require approval. Marketing has substantial restrictions under WHO/Codex codes and national equivalents. Entry requires substantial regulatory work before commercial launch.

How does channel structure vary by market?

Substantially. China is dominated by mother-and-baby specialty retail and e-commerce; major Western markets mix pharmacy, grocery and e-commerce with significant DTC growth; the Middle East is split between pharmacy and modern trade; many emerging markets remain heavily pharmacy-led. Channel structure has material implications for distribution strategy, pricing architecture and partner selection.

How does premium positioning work in infant formula?

Premium positioning combines specific ingredient claims (DHA/ARA levels, prebiotics, probiotics, HMOs, specialty proteins), specific source positioning (grass-fed, organic, A2, sheep, goat), specific manufacturing positioning (single-source milk, particular geography) and brand storytelling around trust and safety. Successful premium brands typically combine two or three of these into a coherent proposition - not just stacking claims.

What is your fee model?

Day rate plus expenses, agreed against a scoped brief. No retainers, no commissions, no contingent fees. Each study is a discrete deliverable.

Further reading: John Watson publishes articles on dairy industry topics on LinkedIn — from infant formula safety and milk supply to plant design, yield improvement and dairy commodity outlook. Browse all articles by John Watson on LinkedIn →

See our related infant formula & powder, infant formula quality, market research, feasibility studies, due diligence and milk powder production cost pages, or browse all consultancy services.